Main page Site map Contacts
  Key participant of the project: Moscow State University (MSU) русский       english
Biomedical project Skulachev ions
Biomedical project Skulachev ions

Home »


24 April 2014
Mitotech S.A., a Luxembourg-based clinical-stage biotechnology company today announced that it has initiated Phase II clinical trial of SkQ1 compound evaluating safety and efficacy of the molecule in patients with moderate to severe dry eye disease.


+7 (495) 939-59-45
  2008 made in:
© 2008-2014 Mitoengineering Centre of MSU